CN Patent

CN103142509B — 一种注射用硼替佐米药物组合物

Assigned to Shijiazhuang Pharmaceutical Group Ouyi Pharma Co Ltd · Expires 2018-01-02 · 8y expired

What this patent protects

为解决硼替佐米稳定性差且溶解性差的技术问题，本发明提供一种硼替佐米药物组合物，所述药物组合物包含质量比为1:2‑100的硼替佐米和氨基酸。本发明可有效提高硼替佐米溶解度，效果与上市产品相当或更优，所提供的硼替佐米药物组合物安全无刺激，处方成本低廉，制备方法简单，稳定性优于现有硼替佐米制剂，有利于工业化生产。

USPTO Abstract

为解决硼替佐米稳定性差且溶解性差的技术问题，本发明提供一种硼替佐米药物组合物，所述药物组合物包含质量比为1:2‑100的硼替佐米和氨基酸。本发明可有效提高硼替佐米溶解度，效果与上市产品相当或更优，所提供的硼替佐米药物组合物安全无刺激，处方成本低廉，制备方法简单，稳定性优于现有硼替佐米制剂，有利于工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN103142509B
Jurisdiction
CN
Classification
—
Expires
2018-01-02
Drug substance claim
No
Drug product claim
No
Assignee
Shijiazhuang Pharmaceutical Group Ouyi Pharma Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.